Company Search:
Advanced Search
Sponsored Links
Zenabis Global Inc Company Snapshot
Zenabis Global Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zenabis Global Inc with three other companies in this sector in Canada: Isodiol International Inc (2018 sales of 19.14 million Canadian Dollars [US$14.33 million] ), Namaste Technologies Inc (18.56 million Canadian Dollars [US$13.90 million] ), and Cronos Group Inc (15.70 million Canadian Dollars [US$11.76 million] ).

Sales Analysis. Zenabis Global Inc reported sales of C$32.79 million (US$24.56 million) for the fiscal year ending June of 2018. This represents a decrease of 1.7% versus 2017, when the company's sales were C$33.35 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zenabis Global Inc
  Stock Performance Chart for Zenabis Global Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 1.99
(Figures in Canadian Dollars)
1 Week -28.4%   13 Weeks -42.0%  
4 Weeks -66.0%   52 Weeks 22.1%  
Zenabis Global Inc Key Data:
  Ticker: ZENA Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 32,791,772
(Year Ending Jan 2019).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 51,970,707
  Fiscal Yr Ends: June Shares Outstanding: 26,115,933
  Share Type: Closely Held Shares: 17,669,222
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.